15.03.2015 Views

February 2012 Drug Update Information - Pharmacy Benefits ...

February 2012 Drug Update Information - Pharmacy Benefits ...

February 2012 Drug Update Information - Pharmacy Benefits ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

500 mg extended release, 500 count (NDC 00378-0352-05) - discontinued<br />

Metformin tablets, Ranbaxy<br />

500 mg, 100 count (NDC 63304-0860-01) - discontinued<br />

d<br />

500 mg, 500 count (NDC 63304-0860-05) - discontinued<br />

d<br />

750 mg, 100 count (NDC 63304-0767-01) - discontinued<br />

d<br />

Metformin tablets, Sandoz<br />

500 mg, 12 x 60 package (NDC 00781-5050<br />

-61)<br />

850 mg, 12 x 60 package (NDC 00781-5051<br />

-61)<br />

1000 mg, 12 x 60 package (NDC<br />

00781-5052-61)<br />

Metformin tablets, Teva<br />

500 mg, 100 count, unit dose (NDC 00093-1048-93) - discontinued<br />

850 mg, 100 count, unit dose (NDC 00093-1049-93) - discontinued<br />

1000 mg, 100 count, unit dose (NDC 00093-7214-93) - discontinuedd<br />

Metformin tablets, UDL<br />

850 mg, 100 count, unit-dose (NDC 51079-0973-20) - discontinued<br />

500 mg, 25 count, unit-dose (NDC 51079-0972-19) - discontinued<br />

500 mg, 100 count, unit-dose (NDC 51079-0972-20) - discontinued<br />

500 mg, 300 count, unit-dose (NDC 51079-0972-56) - discontinued<br />

Metformin tablets, Watson<br />

850 mg, 1000 count (NDC 62037-0675-10) - discontinued<br />

1000 mg, 1000 count<br />

(NDC 62037-0676-10)<br />

- discontinued<br />

Reason for the Shortage<br />

Mylan, UDL, and Teva could not provide a reason for the shortage.<br />

Apotex has metformin products unavailable due to an FDA import ban.<br />

Sandoz has metformin products on shortage due to manufacturing delays.<br />

Ranbaxy<br />

has all discontinued metformin oral<br />

tablets.<br />

Mutual discontinued<br />

all metformin products.<br />

Teva discontinued metformin unit dose presentations in early-August, 2011.<br />

UDL discontinued metformin 500 mg 100 unit dose presentation in late-July, 2011.<br />

Watson discontinued<br />

d metformin 850 mg and<br />

1000 mg presentations.<br />

.<br />

Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=731<br />

Source: http://www.a<br />

ashp.org<br />

Lorazepam injectable presentations<br />

<strong>February</strong><br />

3, <strong>2012</strong><br />

Products Affected - Description<br />

Lorazepam 2 mg/mL, Akorn<br />

1 mL vial (NDC 17478-0040-01)<br />

Lorazepam 2 mg/mL, Bedford<br />

1 mL vial (NDC 55390-0168-10)<br />

- discontinued<br />

10 mL vial (NDC 55390-0170-10) - discontinued<br />

Lorazepam 4 mg/mL, Bedford<br />

1 mL vial (NDC 53390-0169-10)<br />

- discontinued<br />

10 mL vial (NDC 53390-0171-10) - discontinued<br />

Lorazepam 2 mg/mL, Hospira<br />

1 mL iSecure prefilled syringes (NDC 00409-1985-05) - discontinued<br />

1 mL Carpuject syringes (NDC 00409-1985-<br />

-30)<br />

1 mL vial (NDC 00409-6778-02)<br />

10 mL vials (NDC 00409-6780-02)<br />

Lorazepam 4 mg/mL, Hospira<br />

51

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!